Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1960 Sep 3;83(10):532–537.

Home Treatment of Depression with Imipramine (Tofranil)

E J Cleveland, F R Townsend
PMCID: PMC1938772  PMID: 13810673

Full text

PDF
532

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AZIMA H. Imipramine (tofranil); a new drug for the depressed. Can Med Assoc J. 1959 Apr 1;80(7):535–540. [PMC free article] [PubMed] [Google Scholar]
  2. AZIMA H., VISPO R. H. Effects of imipramine (tofranil) on depressive states; a clinical and psychodynamic study. AMA Arch Neurol Psychiatry. 1959 May;81(5):658–664. doi: 10.1001/archneurpsyc.1959.02340170124014. [DOI] [PubMed] [Google Scholar]
  3. AZIMA H., VISPO R. H. Imipramine; a potent new anti-depressant compound. Am J Psychiatry. 1958 Sep;115(3):245–246. doi: 10.1176/ajp.115.3.245. [DOI] [PubMed] [Google Scholar]
  4. FAZIO C., GIBERTI F., LOEB C. Un nuovo trattamento farmacologico (derivato iminodibenzilico G. 22355) nella cura degli stati depressivi. Minerva Med. 1958 Aug 18;49(65-66):3143–3148. [PubMed] [Google Scholar]
  5. KIELHOLZ P., BATTEGAY R. Behandlung depressiver Zustandsbilder, Unterspezieller Berücksichtigung von Tofranil, einem neuen Antidepressivum. Schweiz Med Wochenschr. 1958 Aug 2;88(31):763–767. [PubMed] [Google Scholar]
  6. KUHN R. Uber die Behandlung depressiver Zustände mit einem Iminodibenzylderivat (G 22355). Schweiz Med Wochenschr. 1957 Aug 31;87(35-36):1135–1140. [PubMed] [Google Scholar]
  7. LEHMANN H. E., CAHN C. H., DE VERTEUIL R. L. The treatment of depressive conditions with imipramine (G 22355). Can Psychiatr Assoc J. 1958 Oct;3(4):155–164. doi: 10.1177/070674375800300401. [DOI] [PubMed] [Google Scholar]
  8. MANN A. M., MACPHERSON A. S. Clinical experience with imipramine (G22355) in the treatment of depression. Can Psychiatr Assoc J. 1959 Jan;4(1):38–47. doi: 10.1177/070674375900400111. [DOI] [PubMed] [Google Scholar]
  9. SHERMAN L. J. The significant variables in psychopharmaceutic research. Am J Psychiatry. 1959 Sep;116:208–214. doi: 10.1176/ajp.116.3.208. [DOI] [PubMed] [Google Scholar]
  10. SLOANE R. B., HABIB A., BATT U. E. The use of imipramine (tofranil) for depressive states in open ward settings of a general hospital: a preliminary report. Can Med Assoc J. 1959 Apr 1;80(7):540–546. [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES